about
Far-distant metastases along the CSF pathway of glioblastoma multiforme during continuous low-dose chemotherapy with temozolomide and celecoxib.Pharmacokinetics, pharmacodynamics, safety and tolerability of APG101, a CD95-Fc fusion protein, in healthy volunteers and two glioma patients.Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes.Continuous low-dose temozolomide and celecoxib in recurrent glioblastoma.Long-term adjuvant administration of temozolomide in patients with glioblastoma multiforme: experience of a single institution.Watertight dural closure: is it necessary? A prospective randomized trial in patients with supratentorial craniotomies.Ligamentum flavum hematomas of the cervical and thoracic spine.Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy of glioblastoma multiforme.Recurrence pattern in glioblastoma multiforme patients treated with anti-angiogenic chemotherapy.Circulating endothelial progenitor cells in malignant gliomas.Persistent postpartum headache from a chronic subdural hematoma after peridural anesthesia.Clinical evaluation of the safety and efficacy of lumbar cerebrospinal fluid drainage for the treatment of refractory increased intracranial pressure.Correlation of the Ga-68-bombesin analog Ga-68-BZH3 with receptors expression in gliomas as measured by quantitative dynamic positron emission tomography (dPET) and gene arrays.Pharmacokinetic studies of ⁶⁸Ga-labeled Bombesin (⁶⁸Ga-BZH₃) and F-18 FDG PET in patients with recurrent gliomas and comparison to grading: preliminary results.Episodic hypothermia and hyperhidrosis after subarachnoid hemorrhage. Case illustrationCerebral sinus thrombosis in a trauma patient after recombinant activated factor VII infusionThoracic intramedullary arachnoid cyst in an infant
P50
Q33543830-E75BF818-AA20-4385-9741-8C2BA50CC264Q34263499-B3F28CC9-0A44-415C-AD1D-6E3E33989C93Q39904227-DE3327E0-5E8B-48C2-941F-37FF7729AC29Q42662363-90FA05EA-BC4F-4E01-BB71-35327D35510EQ43072513-E2AD1417-8EC5-4390-B441-89F01DA54029Q43153277-46EA4F67-AE76-4554-950C-D328D5A7FA44Q44030230-3241B1FA-4278-47F1-AA73-F02127FDD901Q45077537-A0F47C17-5EF9-4AA2-AD65-E3C467A727EEQ45163828-C31792AC-20E8-414A-B09D-3B56391DCF2BQ46092458-81CA5363-4791-4774-B6FA-2FB678199DCEQ48573661-DFB1A61A-A7E8-4EFF-94EA-740B676EF15CQ48656734-AD35BEEE-E9A5-49FB-B965-B583F219AAC6Q48721414-5006B615-632C-48A8-8CA1-44A44FB39303Q49065975-8C459241-323D-4981-9CDD-714BF22CACC7Q55463516-E3B1A852-C274-44D1-9638-9187C0DE81BAQ73909305-BB93893E-B223-4308-AB45-0BCE44AC1D79Q75320886-56554C06-7121-4722-9831-B2248E0737BBQ83461676-8B24AEC7-DB6B-46C0-812F-7A120AD7E46E
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Jochen Tuettenberg
@ast
Jochen Tuettenberg
@en
Jochen Tuettenberg
@es
Jochen Tuettenberg
@nl
Jochen Tuettenberg
@sl
type
label
Jochen Tuettenberg
@ast
Jochen Tuettenberg
@en
Jochen Tuettenberg
@es
Jochen Tuettenberg
@nl
Jochen Tuettenberg
@sl
prefLabel
Jochen Tuettenberg
@ast
Jochen Tuettenberg
@en
Jochen Tuettenberg
@es
Jochen Tuettenberg
@nl
Jochen Tuettenberg
@sl
P214
P106
P21
P214
P31
P496
0000-0001-9087-7188
P735
P7859
viaf-30398178